Paul Lammers

Paul Lammers

Company: Triumvira Immunologics

Job title: Chief Executive Officer


Natural Activation of T-Cells Through the TAC Receptor Provides Ideal Characteristics for Adoptive Cell Therapy 1:00 pm

Unique structure and biology of TAC T-cells Deep penetration and activation of TAC T-cells into solid tumors Update on TAC01-HER2 Phase I/II clinical trial in patients with HER2-overexpressing solid tumorsRead more

day: Conference Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.